Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Glancy Binkow & Goldberg Llp
Glancy Binkow & Goldberg LLP - Representing Investors Who Purchased Hardinge Inc. - Announces Update to Shareholder Lawsuit
December 14th, 2008
Glancy Binkow & Goldberg LLP -- representing shareholders of Hardinge Inc. -- announces 33 days remaining to move to be a lead plaintiff in the shareholder lawsuit. All persons or entities who purchased or otherwise acquired the securities of Hardinge Inc. ("Hardinge" or the "Company") (NASDAQ:HDNG), between February 22, 2007 and February 21, 2008, inclusive (the "Class Period"), may move the Court not later than December 29, 2008, to serve as lead plaintiff; however, you must meet certain legal requirements. If you wish to receive a copy of the Complaint, or have any questions concerning your rights or interests with respect to these matters, please contact Michael...
Source: Pharma Investments, Ventures & Law Weekly (2008-12-14)
|
